Scanning NSE · BSE · NYSE · NASDAQ

Marksans Pharma Limited (MARKSANS.NS) share price

Marksans Pharma Limited (NSE:MARKSANS.NS) last traded at INR 303.75, down 3.19% on the day (quote 2026-11-08 09:59 UTC), with a market cap of INR 13766.6 Cr and a 52-week range of INR 155 to INR 350.95.

Key facts for Marksans Pharma Limited
ExchangeNSE
CurrencyINR
Last priceINR 303.75
1-day move-3.19%
52-week rangeINR 155 - INR 350.95
Market capINR 13766.6 Cr
From 52-week high-13.40%
Volume vs average0.1x
Falling Shares risk score16/100 (MODERATE)
CountryIndia
ISININE750C01026

Frequently asked questions

Why is Marksans Pharma Limited falling today?

Marksans Pharma Limited (NSE:MARKSANS.NS) is down 3.19% at its latest quote and trades 13.4% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.

What is the Marksans Pharma Limited share price today?

Marksans Pharma Limited (NSE:MARKSANS.NS) last traded at INR 303.75, a -3.19% move on the day as of 2026-11-08 09:59 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.

What is the 52-week range of Marksans Pharma Limited?

Marksans Pharma Limited's 52-week low is INR 155 and its 52-week high is INR 350.95; the shares trade 13.4% below the high.

What is the market cap of Marksans Pharma Limited?

Marksans Pharma Limited has a market capitalisation of about INR 13766.6 Cr at the latest price.

What are the risks of investing in Marksans Pharma Limited?

Falling Shares Intelligence rates Marksans Pharma Limited 16/100 (MODERATE) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.

Data is compiled from public exchange feeds and may be delayed. Not investment advice.

Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com